Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AVANIR PHARMACEUTICALS | 8,904,746 | reported | 11 Aug 2009 | tx 8+791,477−894,120 |
| EAGLE PHARMACEUTICALS, INC. | 3,779,287 | reported | 20 Mar 2017 | tx 34+4,838,798−4,719,498 |
| CADENCE PHARMACEUTICALS INC | 2,895,282 | reported | 19 Sept 2007 | tx 86+3,053,174−12,384,298 |
| Immune Design Corp. | 2,290,177 | reported | 16 Apr 2015 | tx 7−183,256 |
| OPTIMER PHARMACEUTICALS INC | 10,000 | reported | 08 Jan 2010 | tx 28+2,844,558−1,179,463 |
| NOVADEL PHARMA INC | 0 | reported | 31 Dec 2009 | tx 4+23,237,083−13,034,481 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Mar 2017 | SALE | EAGLE PHARMACEUTICALS, INC. | 38,997 | 82.01 USD | |
| 16 Mar 2017 | SALE | EAGLE PHARMACEUTICALS, INC. | 9,120 | 82.08 USD | |
| 20 Mar 2017 | SALE | EAGLE PHARMACEUTICALS, INC. | 51,883 | 82.10 USD | |
| 06 Sept 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 12,958 | 62.45 USD | |
| 06 Sept 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 12,224 | 63.25 USD | |
| 06 Sept 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 49 | 62.83 USD | |
| 06 Sept 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 166 | 62.83 USD | |
| 07 Sept 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 11,345 | 62.26 USD | |
| 07 Sept 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 22 | 62.26 USD | |
| 07 Sept 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 75 | 62.26 USD | |
| 08 Sept 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 33,796 | 62.33 USD | |
| 08 Sept 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 66 | 62.33 USD | |
| 08 Sept 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 224 | 62.33 USD | |
| 04 Jan 2016 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 21 Apr 2015 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10,000 | 0.00 USD | deriv |
| 14 Apr 2015 | SALE | Immune Design Corp. | 13,814 | 27.26 USD | |
| 16 Apr 2015 | SALE | Immune Design Corp. | 100 | 26.75 USD | |
| 15 Apr 2015 | SALE | Immune Design Corp. | 100 | 29.17 USD | |
| 15 Apr 2015 | SALE | Immune Design Corp. | 39,900 | 28.57 USD | |
| 13 Mar 2015 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 5,000 | 0.00 USD | deriv |
| 12 Mar 2015 | SALE | Immune Design Corp. | 94,199 | 24.94 USD | |
| 10 Mar 2015 | SALE | Immune Design Corp. | 6,143 | 24.65 USD | |
| 11 Mar 2015 | SALE | Immune Design Corp. | 29,000 | 25.02 USD | |
| 08 Apr 2014 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 4,680 | 0.00 USD | deriv |
| 18 Feb 2014 | CONVERSION | EAGLE PHARMACEUTICALS, INC. | 1,927,986 | — |
1 purchase reported after at least 12 months of silence — most recent on 18 Feb 2014.